Search results for "Type 2"

showing 10 items of 1034 documents

Relationship between erectile dysfunction and silent myocardial ischemia in type 2 diabetic patients with no known macrovascular complications.

2011

ABSTRACT Introduction Erectile dysfunction (ED) is associated with cardiovascular disease (CVD) because it is highly prevalent among those with cardiovascular risk factors (CVRFs). Moreover, it precedes the development of CVD and is considered a subrogate marker of subclinical CVD. Aim The aim of this study was to evaluate the presence of ED among patients with type 2 diabetes (DM2) without macroangiopathy, and to assess the association between ED and other CVRFs, chronic diabetes complications, silent myocardial ischemia (SMI), and peripheral arterial disease (PAD). Methods One hundred fifty‐four male patients with DM2 and without clinical evidence of CVD were included in the study. The pr…

Malemedicine.medical_specialtyUrologyEndocrinology Diabetes and MetabolismMyocardial IschemiaType 2 diabetesAsymptomaticNephropathyPeripheral Arterial DiseaseEndocrinologyInsulin resistanceErectile DysfunctionDiabetes mellitusInternal medicinemedicinePrevalenceHumansAnkle Brachial Indexcardiovascular diseasesmedicine.diagnostic_testbusiness.industryAge FactorsMiddle Agedmedicine.diseaseSurgeryPsychiatry and Mental healthErectile dysfunctionBlood pressureDiabetes Mellitus Type 1Reproductive MedicineHypertensionCardiologymedicine.symptomLipid profilebusinessThe journal of sexual medicine
researchProduct

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

2006

BACKGROUND: The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known. METHODS: We evaluated rosiglitazone, metformin, and glyburide as initial treatment for recently diagnosed type 2 diabetes in a double-blind, randomized, controlled clinical trial involving 4360 patients. The patients were treated for a median of 4.0 years. The primary outcome was the time to monotherapy failure, which was defined as a confirmed level of fasting plasma glucose of more than 180 mg per deciliter (10.0 mmol per liter), for rosiglitazone, as compared with metformin or glyburide. Prespecified secondary…

Malemedicine.medical_specialtyUrologyKaplan-Meier EstimateType 2 diabetesPharmacologyWeight GainRosiglitazoneGlibenclamidechemistry.chemical_compoundDouble-Blind MethodDiabetes mellitusGlyburidemedicineHumansHypoglycemic AgentsProportional Hazards ModelsGlycemicGlycated HemoglobinGlycemic efficacyWaist-Hip Ratiobusiness.industryCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseMetforminMetforminTreatment OutcomeDiabetes Mellitus Type 2chemistryCardiovascular DiseasesFemaleThiazolidinedionesGlycated hemoglobinbusinessRosiglitazonemedicine.drugNew England Journal of Medicine
researchProduct

Dietary intake of vitamin K is inversely associated with mortality risk

2014

Vitamin K has been related to cardiovascular disease and cancer risk. However, data on total mortality are scarce. The aimof the present study was to assess the association between the dietary intake of different types of vitamin K and mortality in a Mediterranean population at high cardiovascular disease risk. A prospective cohort analysis was conducted in 7216 participants from the PREDIMED (Prevención con Dieta Mediterránea) study (median follow-up of 4.8 y). Energy and nutrient intakes were evaluated using a validated 137-item food frequency questionnaire. Dietary vitamin K intake was calculated annually using the USDA food composition database and other published sources. Deaths were a…

Malemedicine.medical_specialtyVitamin KPopulationMedicine (miscellaneous)Diet MediterraneanLower riskNational Death IndexDIETA MEDITERRÀNIARisk FactorsNeoplasmsInternal medicineDiabetes mellitusVegetablesEstà en blancmedicineHumansPlant OilsProspective StudiesVITAMINES KProspective cohort studyeducationMALALTIES CARDIOVASCULARS / PREVENCIÓAgedProportional Hazards ModelsCiències de la salutAged 80 and overeducation.field_of_studyNutrition and DieteticsMediterranean RegionProportional hazards modelbusiness.industryIncidenceIncidence (epidemiology)ConfoundingHealth sciencesVitamin K 2Vitamin K 1Middle Agedmedicine.diseaseCiencias de la saludEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesFemalebusiness0022-3166Follow-Up Studies
researchProduct

Cross-sectional associations of objectively-measured sleep characteristics with obesity and type 2 diabetes in the PREDIMED-Plus trial.

2018

Study Objectives: To examine independent and combined associations of sleep duration and sleep variability with body composition, obesity and type 2 diabetes (T2D) in elders at high cardiovascular risk. Methods: Cross-sectional analysis of 1986 community-dwelling elders with overweight/obesity and metabolic syndrome from PREDIMEDPlus trial. Associations of accelerometry-derived sleep duration and sleep variability with body mass index (BMI), waist circumference (WC) and body composition were assessed fitting multivariable-adjusted linear regression models. Prevalence ratios (PR) and 95% confidence intervals (CI) for obesity and T2D were obtained using multivariable-adjusted Cox regression w…

Malemedicine.medical_specialtyWaist030209 endocrinology & metabolismType 2 diabetesOverweightBody Mass Index03 medical and health sciences0302 clinical medicineRisk FactorsPhysiology (medical)Internal medicineSleep Initiation and Maintenance DisordersAccelerometrymedicineHumansObesityAdiposityAgedMetabolic Syndromebody compositionnight-to-night sleep variabilitybusiness.industryMiddle Agedmedicine.diseaseObesityConfidence intervalCross-Sectional StudiesDiabetes Mellitus Type 2sleep durationFemaleNeurology (clinical)Android fat distributiontype 2 diabetesmedicine.symptomMetabolic syndromeWaist CircumferencebusinessSleepBody mass index030217 neurology & neurosurgery
researchProduct

Serum 25-Hydroxyvitamin D and Incidence of Diabetes in Elderly People: The PRO.V.A. Study

2014

Context: Increasing research has shown that low levels of serum 25-hydroxyvitamin (25OHD) predict the onset of diabetes, but no research is available on this issue in elderly people. Objective: Our objective was to examine whether low serum levels of 25OHD are associated with a higher risk of incident type 2 diabetes over a lengthy follow-up in a representative group of elderly people. Design and Setting: This was a population-based cohort study as part of the Progetto Veneto Anziani (Pro.V.A.) Study over a follow-up of 4.4 years in the general community. Participants: Participants included 2227 participants (1728 with follow-up visits and 499 died during the follow-up) over 65 years of ag…

Malemedicine.medical_specialtyWaistEndocrinology Diabetes and MetabolismClinical BiochemistryPopulationContext (language use)Type 2 diabetesBiochemistrynot knownCohort StudiesEndocrinologyInternal medicineDiabetes mellitusmedicineHumansVitamin DeducationAgedAged 80 and overeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Biochemistry (medical)Vitamin D Deficiencymedicine.diseaseEndocrinologyDiabetes Mellitus Type 2ItalyFemalebusinessBody mass indexCohort studyThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review

2020

Reduction of hazard risk of cerebral ischemic event (stroke, transient ischemic attack (TIA)) represents the hard point to be achieved from primary or secondary preventive strategy in the best clinical practice. However, results from clinical trials, recommendations, guidelines, systematic review, expert opinions, and meta-analysis debated on the optimal pharmacotherapy to achieve the objective. Aspirin and a number of antiplatelet agents, alone or in combination, have been considered from large trials focused on stroke prevention. The present review summarizes, discusses results from trials, and focuses on the benefits or disadvantages originating from antiplatelet drugs. Sections of the r…

Malemedicine.medical_specialtyaspirinHealth Toxicology and Mutagenesisdipyridamolelcsh:MedicineStroke.Review030204 cardiovascular system & hematology03 medical and health sciencesTherapeutic approach0302 clinical medicinePharmacotherapyDouble-Blind MethodpreventionSecondary PreventionmedicineHumanscardiovascular diseasesIntensive care medicineStrokeAgedclopidogrelAspirinPreventive strategybusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMiddle AgedClopidogrelmedicine.diseasestrokecombined drug therapyClinical trialDiabetes Mellitus Type 2Ischemic Attack TransientStroke preventionDrug Therapy CombinationFemalebusinesscilostazolPlatelet Aggregation Inhibitors030217 neurology & neurosurgerymedicine.drugInternational Journal of Environmental Research and Public Health
researchProduct

Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases

2011

In the last few decades, the prevalence of overweight and essential obesity has been undergoing a fast and progressive worldwide increase. Obesity has been in turn linked to type II diabetes, with the total number of diabetic patients worryingly increasing, in the last fifteen years, suggesting a pandemic phenomenon. At the same time, an increase in the prevalence of cardiovascular diseases has been also recorded. Increasing evidence suggests that the diet is involved in such escalation. In particular, the progressive globalization of food industry allowed massive supply, at a relatively low price, of a great variety of pre-packed food and bakery products, with very high energy content. Mos…

Malemedicine.medical_specialtycoronary heart disease (CHD)Endocrinology Diabetes and MetabolismTransportCoronary DiseaseType 2 diabetesOverweightEndocrinologyInsulin resistanceRisk FactorsSettore BIO/10 - BiochimicaInternal medicineDiabetes mellitusPrevalencemedicineHumansObesityMetabolic Syndromechemistry.chemical_classificationtype 2 diabeteFree fatty acidbusiness.industryFatty AcidsMetabolismTrans Fatty AcidsFatty acidsignaling fatty acidLipid Metabolismmedicine.diseaseDietary FatsObesityDietMetabolismEndocrinologychemistryFemaleFFA-dependent β-cell apoptosiHydrogenationInsulin Resistancemedicine.symptomMetabolic syndromebusinessDiabetic AngiopathiesPolyunsaturated fatty acidCurrent Diabetes Reviews
researchProduct

Differences in clinical and biological characteristics and prevalence of chronic complications related to aging in patients with type 2 diabetes

2015

Type 2 diabetes mellitus (T2DM) is a chronic, highly prevalent disease that increases with age. Because of this, and due to its chronic complications, T2DM causes high human, social, and financial costs. In addition, the elderly population with T2DM has a marked clinical heterogeneity. Therefore, our main objective was to analyze the relationship of age with the clinical and biological manifestations of the disease and the prevalence of chronic complications in patients with T2DM.A cross-sectional study of a large population with T2DM (n=405) randomly selected from a Diabetes Unit and 2 health care centers (60%). The clinical, anthropometric, and biochemical variables of the subjects were c…

Malemedicine.medical_specialtyendocrine system diseasesCross-sectional studyBlood Pressure030209 endocrinology & metabolismDiseaseType 2 diabetes03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinePrevalencemedicineHumans030212 general & internal medicineTriglyceridesAgedMetabolic Syndromebusiness.industryAge Factorsnutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseaseSurgeryCross-Sectional StudiesDiabetes Mellitus Type 2FemaleWaist CircumferenceMetabolic syndromebusinessPolyneuropathyKidney diseaseEndocrinología y Nutrición (English Edition)
researchProduct

Metformin and contrast-induced acte kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevati…

2016

IF 4.638; International audience; AIM : To analyze the association between chronic metformin treatment and the development of contrast-induced acute kidney injury (CI-AKI) after primary percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI).METHODS: Patients with type 2 diabetes mellitus (T2DM) treated with PCI 27μmol/l (0.3mg/dl) or >50% over baseline after PCI. Since PCI was urgent, metformin could not be withheld prior to PCI but was usually stopped after PCI.RESULTS:Among the 372 patients included, 147 (40%) were using metformin, which had older diabetes, but had risk factors similar to patients without metformin. Baseline eGFR was better in pati…

Malemedicine.medical_specialtyendocrine system diseasesMedication Therapy Managementmedicine.medical_treatmentStatistics as TopicContrast Media030204 cardiovascular system & hematologyCoronary AngiographyRisk Assessment03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsST segment030212 general & internal medicineMyocardial infarctioncardiovascular diseasesAgedbusiness.industryPrimary percutaneous coronary interventionAcute kidney injuryPercutaneous coronary interventionnutritional and metabolic diseasesMiddle Aged[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseaseST segment elevation segment myocardial infarctionMetformin3. Good healthMetforminAcute kidney injuryDiabetes Mellitus Type 2CreatinineConventional PCICardiologyST Elevation Myocardial InfarctionFemaleFranceCardiology and Cardiovascular MedicinebusinessKidney diseasemedicine.drug
researchProduct

Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects.

2012

Peripheral polyneuropathy (PN) is a frequent complication of diabetes. However, mechanisms underlying the development of PN are multifactorial and not well understood. Our aim was to examine the association of plasma homocysteine (Hcy) with the prevalence and grade of peripheral PN in patients with type 2 diabetes (T2DM). We studied a cohort of 196 subjects with T2DM classified according to the grade of PN (Neuropathy Disability Score, NDS). Subjects with the highest grade of PN were older and had significantly increased levels of creatinine, microalbuminuria, HbA1c, and plasma Hcy compared to the other two groups. The differences in plasma Hcy values were maintained after correcting for co…

Malemedicine.medical_specialtyendocrine system diseasesType 2 diabetesGastroenterologyCohort Studieschemistry.chemical_compoundDiabetic NeuropathiesInternal medicineDiabetes mellitusmedicineHumansProspective cohort studyHomocysteineAgedCreatininebusiness.industryGeneral NeuroscienceConfoundingnutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseaseEndocrinologychemistryDiabetes Mellitus Type 2CohortMicroalbuminuriaFemaleNeurology (clinical)businessJournal of the peripheral nervous system : JPNS
researchProduct